Director, Global Market Access & Pricing

Overview

At Genmab, we are dedicated to building extra[not]ordinary futures together, by developing antibody products and pioneering, knock-your-socks-off therapies that change the lives of patients and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly unique, determined to be our best, and authentic is essential to fulfilling our purpose.

Does this inspire you and feel like a fit? Then we would love to have you join us!

Director Global Market Access and Pricing, Solid Tumor

The Director Global Market Access & Pricing Solid Tumor will be responsible for developing and executing differentiated global market access and pricing strategies demonstrating the value of one or more of our oncology assets to HTA bodies and payers to ensure optimal patient access. The ideal candidate will have a solid analytical background, strategic thinking as well as a deep understanding of US / EU / Japan regional healthcare systems, payer preferences, and market dynamics to lead the market access and pricing launch strategies.

This position is hybrid based in Princeton, NJ (US) and will report to the Senior Director or VP of Global Market Access and Pricing.

• Lead the development of Global Integrated Access and Pricing strategies in collaboration with the cross-functional team to maximize the value of assigned asset(s).
• Provide strategic market access input to inform global clinical development program of assigned asset(s) and ensure it is optimized to meet the needs of global payers (e.g., relevant endpoints, trial design, sub-populations, evidence of cost offsets) by incorporating HTA and payers' perspectives gained through early HTA engagement, ad boards, primary payer research, and analysis of select secondary research.
• Develop and maintain strong business relationships with key functions responsible for value proposition enablement with a focus on clinical, commercial, regulatory, medical affairs, and HEOR stakeholders.
• Proactively identify and communicate evidence requirements for successful access and support the development of evidence generation plans in collaboration with HEOR.
• Collaborate with Market Access colleagues (Global and in countries) to drive alignment, optimize support, and promote efficiency and best practice sharing.
• Monitor, analyze and communicate Global market access and pricing trends, competitor activities, and policy changes to anticipate future market dynamics and adjust strategies accordingly.
• Support the execution of broader market access goals, including pricing targets, access timelines, and overall launch success.
• Plan and contribute to JCA submission.

• Ph.D., Pham D, MD, or M.Sc. in appropriate field (Health Economics, Public Health, or Health Policy).
• 10+ years of relevant experience working within a similar organization including international exposure within a leadership position.
• Strong experience in pricing and reimbursement of oncology products with specific knowledge of and demonstrated experience in one of the key HTA markets (i.e., UK, Germany, France).
• Strong experience with pricing regulations and a hands-on role in early and launch Pricing analysis. Hands-on experience with country pricing negotiations is a plus.
• Demonstrable experience supporting the early global development plans to meet the evidence requirements for the various downstream market access stakeholders.
• Proven track record of success within developing desirable value propositions and access strategies.
• Demonstrated knowledge of global policy trends, tactics, and HTA/payer dynamics incl. regional developments (e.g., JCA, IRA).
• Experience in making market access recommendations on products in development and suggesting changes for optimization of market access.
• Demonstrated success in managing multiple activities (both "self" and…